Clinicopathologic analysis of patients with BK viruria and rejection-like graft dysfunction

Human Pathology

Volumn 40, Issue 9, 2009, Pages 1312-1319

  Batal, Ibrahim ^a   Franco, Zachary M ^a   Shapiro, Ron ^a   Basu, Amit ^a   Tan, Henkie ^a   Kayler, Liise ^b   Zeevi, Adriana ^a   Morgan, Claire ^a   Randhawa, Parmjeet ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

BK virus; C4d; Immune cell function; Viremia; Viruria

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BK VIRUS; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; INTERSTITIAL NEPHRITIS; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; MALE; NUCLEOTIDE SEQUENCE; RENAL GRAFT DYSFUNCTION; VIRUS ETIOLOGY; VIRUS INFECTION; VIRUS LOAD;

ANTIGENS, CD4; BK VIRUS; CREATININE; DNA, VIRAL; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; IN SITU HYBRIDIZATION; KIDNEY TRANSPLANTATION; NEPHRITIS, INTERSTITIAL; POLYOMAVIRUS INFECTIONS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; URINE; VIRAL LOAD; VIREMIA;

EID: 68349134830     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.01.018     Document Type: Article

References (29)

1. Mylonakis E., Goes N., Rubin R.H., et al. BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation 72 (2001) 1587-1592
2. Randhawa P., and Brennan D.C. BK virus infection in transplant recipients: an overview and update. Am J Transplant 6 (2006) 2000-2005
3. Ahuja M., Cohen E.P., Dayer A.M., et al. Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation 71 (2001) 896-899
4. Hurault de Ligny B., Etienne I., Francois A., et al. Polyomavirus-induced acute tubulo-interstitial nephritis in renal allograft recipients. Transplant Proc 32 (2000) 2760-2761
5. Mathur V.S., Olson J.L., Darragh T.M., et al. Polyomavirus-induced interstitial nephritis in two renal transplant recipients: case reports and review of the literature. Am J Kidney Dis 29 (1997) 754-758
6. Nickeleit V., Hirsch H.H., Binet I.F., et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol 10 (1999) 1080-1089
7. Ramos E., Drachenberg C.B., Papadimitriou J.C., et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 13 (2002) 2145-2151
8. Randhawa P.S., Finkelstein S., Scantlebury V., et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 67 (1999) 103-109
9. Celik B., Shapiro R., Vats A., et al. Polyomavirus allograft nephropathy: sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression. Am J Transplant 3 (2003) 1378-1382
10. Josephson M.A., Williams J.W., Chandraker A., et al. Polyomavirus-associated nephropathy: update on antiviral strategies. Transpl Infect Dis 8 (2006) 95-101
11. Nickeleit V., Klimkait T., Binet I.F., et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 342 (2000) 1309-1315
12. Vats A., Shapiro R., Singh Randhawa P., et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 75 (2003) 105-112
13. Racusen L.C., Solez K., Colvin R.B., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 55 (1999) 713-723
14. Kowalski R., Post D., Schneider M.C., et al. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 17 (2003) 77-88
15. Kowalski R.J., Post D.R., Mannon R.B., et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 82 (2006) 663-668
16. Randhawa P., Ho A., Shapiro R., et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol 42 (2004) 1176-1180
17. Racusen L.C., Colvin R.B., Solez K., et al. Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3 (2003) 708-714
18. Solez K., Colvin R.B., Racusen L.C., et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 8 (2008) 753-760
19. Batal I., Girnita A., Zeevi A., et al. Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney. Mod Pathol 21 (2008) 1490-1498
20. Kayler L.K., Kiss L., Sharma V., et al. Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. Transplantation 85 (2008) 813-820
21. Shapiro R., Jordan M.L., Basu A., et al. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg 238 (2003) 520-525 [discussion 525-27]
22. Tan H.P., Donaldson J., Basu A., et al. Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. Am J Transplant, (2008)
23. Kayler L.K., Batal I., Mohanka R., et al. Antirejection treatment in kidney transplant patients with BK viruria. Transplantation 86 (2008) 797-803
24. Kayler L.K., Mohanka R., Morgan C., et al. Clinical course of kidney transplant patients with acute rejection and BK virus replication following Campath therapy. Clin Transplant 22 (2008) 348-353
25. Wadei H.M., Rule A.D., Lewin M., et al. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant 6 (2006) 1025-1032
26. Randhawa P., Vats A., and Shapiro R. Monitoring for polyomavirus BK And JC in urine: comparison of quantitative polymerase chain reaction with urine cytology. Transplantation 79 (2005) 984-986
27. Brennan D.C., Agha I., Bohl D.L., et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 5 (2005) 582-594
28. Almeras C., Foulongne V., Garrigue V., et al. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study. Transplantation 85 (2008) 1099-1104
29. Batal I., Zeevi A., Heider A., et al. Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation. Am J Clin Pathol 129 (2008) 587-591